These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34382876)

  • 1. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies.
    Fang CY; Liu CC
    Expert Opin Drug Discov; 2022 Jan; 17(1):27-39. PubMed ID: 34382876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease.
    Fang CY; Liu CC
    Expert Rev Vaccines; 2018 Sep; 17(9):819-831. PubMed ID: 30095317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is a multivalent hand, foot, and mouth disease vaccine feasible?
    Klein M; Chong P
    Hum Vaccin Immunother; 2015; 11(11):2688-704. PubMed ID: 26009802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases.
    Mao Q; Wang Y; Bian L; Xu M; Liang Z
    Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems.
    Bian L; Gao F; Mao Q; Sun S; Wu X; Liu S; Yang X; Liang Z
    Expert Rev Anti Infect Ther; 2019 Apr; 17(4):233-242. PubMed ID: 30793637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antiviral activity of medicinal mushroom Ganoderma neo-japonicum Imazeki against enteroviruses that caused hand, foot and mouth disease.
    Ang WX; Sarasvathy S; Kuppusamy UR; Sabaratnam V; Tan SH; Wong KT; Perera D; Ong KC
    Trop Biomed; 2021 Sep; 38(3):239-247. PubMed ID: 34362866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
    Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
    Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress and challenges in drug development to fight hand, foot and mouth disease.
    Lim ZQ; Ng QY; Ng JWQ; Mahendran V; Alonso S
    Expert Opin Drug Discov; 2020 Mar; 15(3):359-371. PubMed ID: 31470744
    [No Abstract]   [Full Text] [Related]  

  • 9. Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: Essential information for rational vaccine design.
    Hoa-Tran TN; Dao ATH; Nguyen AT; Kataoka C; Takemura T; Pham CH; Vu HM; Hong TTT; Ha NTV; Duong TN; Thanh NTH; Shimizu H
    Vaccine; 2020 Dec; 38(52):8273-8285. PubMed ID: 33223308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spatial-temporal distribution and etiological characteristics of hand-foot-and-mouth disease before and after EV‑A71 vaccination in Kunming, China, 2017-2020.
    Wang M; Chen T; Peng J; Luo Y; Du L; Lu Z; He J; Liu C; Gan Q; Ma W; Cun Z; Zheng Q; Chen W; Chen Y; Han M; Liu G; Li J
    Sci Rep; 2022 Oct; 12(1):17028. PubMed ID: 36220850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study.
    Li Y; Zhou Y; Cheng Y; Wu P; Zhou C; Cui P; Song C; Liang L; Wang F; Qiu Q; Guo C; Zeng M; Long L; Cowling BJ; Yu H
    Lancet Child Adolesc Health; 2019 Oct; 3(10):697-704. PubMed ID: 31375313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming, China.
    Jiang H; Zhang Z; Rao Q; Wang X; Wang M; Du T; Tang J; Long S; Zhang J; Luo J; Pan Y; Chen J; Ma J; Liu X; Fan M; Zhang T; Sun Q
    Emerg Microbes Infect; 2021 Dec; 10(1):619-628. PubMed ID: 33682641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology and clinical features of hand, foot and mouth disease requiring hospitalization after the use of enterovirus A71 inactivated vaccine in chengdu, China, 2017-2022: a descriptive study.
    Duan X; Zhang C; Wang X; Ren X; Peng H; Tang X; Zhang L; Chen Z; Ye Y; Zheng M; Zhong W; Chen X; Zeng Y; Yuan P; Long L
    Emerg Microbes Infect; 2022 Dec; 11(1):2510-2519. PubMed ID: 36103331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy.
    Aswathyraj S; Arunkumar G; Alidjinou EK; Hober D
    Med Microbiol Immunol; 2016 Oct; 205(5):397-407. PubMed ID: 27406374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of single-step multiplex real-time RT-PCR assays for rapid diagnosis of enterovirus 71, coxsackievirus A6, and A16 in patients with hand, foot, and mouth disease.
    Puenpa J; Suwannakarn K; Chansaenroj J; Vongpunsawad S; Poovorawan Y
    J Virol Methods; 2017 Oct; 248():92-99. PubMed ID: 28662914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hand, Foot, and Mouth Disease in China: Modeling Epidemic Dynamics of Enterovirus Serotypes and Implications for Vaccination.
    Takahashi S; Liao Q; Van Boeckel TP; Xing W; Sun J; Hsiao VY; Metcalf CJ; Chang Z; Liu F; Zhang J; Wu JT; Cowling BJ; Leung GM; Farrar JJ; van Doorn HR; Grenfell BT; Yu H
    PLoS Med; 2016 Feb; 13(2):e1001958. PubMed ID: 26882540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemical and etiological study on hand, foot and mouth disease following EV-A71 vaccination in Xiangyang, China.
    Meng XD; Tong Y; Wei ZN; Wang L; Mai JY; Wu Y; Luo ZY; Li S; Li M; Wang S; Wei S; Gong W; Zhang W; Hu X; Huang J; Shi J; Yang G; Meng S; Wang Z; Guan X; Shen S
    Sci Rep; 2020 Dec; 10(1):20909. PubMed ID: 33262488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of enterovirus A71 vaccine against pediatric HFMD and disease profile of post-vaccination infection.
    Duan X; Zhang L; Ding L; Zhang C; Chen Z; Cheng Y; Wang X; Peng H; Tang X; Ren X; Liao J; Yang S; Zhu Y; Luo W; Zeng Y; Yuan P; Long L
    Vaccine; 2024 Apr; 42(9):2317-2325. PubMed ID: 38433065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines.
    Zhang X; Zhang Y; Li H; Liu L
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxsackievirus A6 was the most common enterovirus serotype causing hand, foot, and mouth disease in Shiyan City, central China.
    Li JF; Zhang CJ; Li YW; Li C; Zhang SC; Wang SS; Jiang Y; Luo XB; Liao XJ; Wu SX; Lin L
    World J Clin Cases; 2022 Nov; 10(31):11358-11370. PubMed ID: 36387823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.